AIMing for Tokyo

Tokyo AIM finally looks to be getting its first-ever listing, as drug delivery cancer play Mebiopharm Co. Ltd. last week filed to raise an undisclosed amount in an IPO on the exchange.

Tokyo AIM was jointly established in 2009 by the Tokyo Stock Exchange Group, which holds 51%, and the London Stock Exchange, which holds 49%...